DYNEX CAPITAL INC (DX)
Dynex Capital, Inc. Announces First Quarter 2026 Results
Dynex Capital, Inc. Announces First Quarter 2026 Results
TTP Group Announces the Sale of LEX Diagnostics
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School
Net Asset Value(s)
Register of shareholders, changes and capital status – conversion into shares of BONDS series 2
Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile
RedCloud to Enter Live Deployment Phase as Combined Turkey and Saudi Joint Ventures Represent Up to $80 Million Revenue
Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease
Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile
Psyence BioMed Positioned as Worlds only Licensed Pharmaceutical Grade Ibogaine Supplier at Source